Mirum Pharmaceuticals, Inc. (MIRM) stock
MIRMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$93.99+0.66 (+0.71%)
Close on Nov 13, 2026Market cap $6.10BP/E –Yield –
Mirum Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Mirum Pharmaceuticals's enterprise value was $5.69B on Nov 11, 2026, against $3.37B a year earlier. Over the last 5 years it ranged from $294.95M to $6.75B, with a median of $1.31B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $5.69B | +54.7% |
| 2025 | Dec 31, 2025 | $3.68B | +116.5% |
| 2024 | Dec 31, 2024 | $1.70B | +58.9% |
| 2023 | Dec 29, 2023 | $1.07B | +100.8% |
| 2022 | Dec 30, 2022 | $532.52M | +80.5% |
| 2021 | Dec 31, 2021 | $294.95M | -3.7% |
| 2020 | Dec 31, 2020 | $306.43M | -28.2% |
| 2019 | Dec 31, 2019 | $427.08M | – |
See a number that looks wrong?